Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
1.
J Mater Sci Mater Med ; 32(7): 76, 2021 Jun 22.
Article in English | MEDLINE | ID: mdl-34156576

ABSTRACT

Although the incorporation of bioactive glasses into glass ionomer cements (GICs) has led to promising results, using a bioactive glass as the only solid component of GICs has never been investigated. In this study, we developed an Al-free GIC with standard compressive strength using various combinations of 45S5 Bioglass® and its glass-ceramic as the solid component. The glass-ceramic particles with 74% crystallinity were used for this purpose as they can best act as both remineralizing and reinforcing agents. Strengthening mechanisms including crack deflection and crack-tip shielding were activated for the GICs containing 50-50 wt% bioglass and bioglass-ceramic as the optimum ratio. The progression of the GIC setting reaction at its early stages was also monitored and verified. We also discussed that our bimodal particle size distribution containing both micron- and nanosized particles may enhance the packing density and integrity of the structure of the cements after setting. In such GICs produced in this study, the toxic effects of Al are avoided while chemical bonds are expected to form between the cement and the surrounding hard tissue(s) through interfacial biomineralization and adhesion.


Subject(s)
Aluminum/chemistry , Ceramics/chemistry , Glass Ionomer Cements/chemistry , Bone Cements , Compressive Strength , Glass/chemistry , Hardness , In Vitro Techniques , Materials Testing , Nanoparticles/chemistry , Particle Size , Powders , Spectroscopy, Fourier Transform Infrared , Stress, Mechanical , Surface Properties , Tensile Strength , X-Ray Diffraction
2.
J Mech Behav Biomed Mater ; 97: 396-405, 2019 09.
Article in English | MEDLINE | ID: mdl-31174045

ABSTRACT

The clinical applications of glass ionomer cements (GICs) are limited by their relatively poor mechanical properties and insufficient remineralizing capacity. In this study, we developed hybrid GICs with improved mechanical and remineralizing properties via incorporation of an optimum amount (5 wt%) of 45S5 bioglass-ceramic particles. Also, we found that bioglass-ceramic particles with 74% crystallinity best act as both remineralizing and reinforcing agents. The degree of crystallinity of the additives, is overlooked in this context in other research. At around 74% crystallinity, there is sufficient amount of combeite and an amorphous phosphorous-rich phase in the 45S5 bioglass-ceramic particles to respectively promote their reinforcing role and allow them to effectively partake in the setting process creating an excellent interfacial bond with the GIC matrix. As a result, several strengthening mechanisms such as crack deflection and crack-tip shielding are activated within the hybrid GIC containing 5 wt% bioglass-ceramic with 74% crystallinity, contributing to its improved mechanical properties. The enhanced remineralizing and mechanical properties of such hybrid GICs can potentially improve their in vivo performance and broaden their clinical applications.


Subject(s)
Ceramics/chemistry , Glass Ionomer Cements/chemistry , Glass/chemistry , Materials Testing , Body Fluids , Compressive Strength , Hardness , Hot Temperature , Hydrogen-Ion Concentration , Phosphorus/chemistry , Powders , Spectroscopy, Fourier Transform Infrared , Stress, Mechanical , Tensile Strength
3.
Materials (Basel) ; 12(10)2019 May 24.
Article in English | MEDLINE | ID: mdl-31137682

ABSTRACT

Highly expanded, low-cost aluminum-based foams were successfully produced via powder metallurgy using dolomite as foaming agent. Nickel additions (5-15 wt.%) were explored in order to reduce the temperature disparity between dolomite decomposition and the melting range of the metallic matrix. Specific Al-Ni compositions provide appropriate viscosities for effective encapsulation of CO2 gas released during dolomite decomposition. A partial sintering step of compacted precursors was introduced prior to foaming, which resulted in high porosity levels (~86%) and significant volume expansion (~250%) in the final product. The partial sintering technique was a key determining factor in obtaining stable, highly expanded cellular structures with homogeneous pores, averaging 3 mm in size and being morphologically comparable with ALPORASTM foams.

4.
Eye (Lond) ; 32(2): 375-383, 2018 02.
Article in English | MEDLINE | ID: mdl-28912515

ABSTRACT

PurposeTo evaluate the sensitivity and specificity of a portable non-mydriatic fundus camera to diagnose vision-threatening diabetic retinopathy (VTDR).Patients and methodsA prospective, single-site, comparative instrument validation study was undertaken at the Aravind Eye Care System. Overall, 155 subjects with and without diabetes were recruited. Images from 275 eyes were obtained with the (1) non-mydriatic Smartscope, (2) mydriatic Smartscope, and (3) mydriatic table-top camera of the macular, nasal, and superotemporal fields. A retina specialist performed a dilated fundus examination (DFE), (reference standard). Two masked retina specialists graded the images. Sensitivity and specificity to detect VTDR with the undilated Smartscope was calculated compared to DFE.ResultsGraders 1 and 2 had a sensitivity of 93% (95% confidence interval (CI): 87-97%) and 88% (95% CI: 81-93%) and a specificity of 84% (95% CI: 77-89%) and 90% (95% CI: 84-94%), respectively, in diagnosing VTDR with the undilated Smartscope compared to DFE. Compared with the dilated Topcon images, graders 1 and 2 had sensitivity of 88% (95% CI: 81-93%) and 82% (95% CI: 73-88%) and specificity of 99% (95% CI: 96-100%) and 99% (95% CI: 95-100%).ConclusionsRemote graders had high sensitivity and specificity in diagnosing VTDR with undilated Smartscope images, suggesting utility where portability is a necessity.


Subject(s)
Diabetic Retinopathy/diagnostic imaging , Mass Screening/methods , Ophthalmoscopy/methods , Adult , Aged , Case-Control Studies , Female , Humans , India , Male , Middle Aged , Photography/methods , Prospective Studies , Sensitivity and Specificity
6.
J Biomed Mater Res B Appl Biomater ; 105(8): 2433-2442, 2017 Nov.
Article in English | MEDLINE | ID: mdl-27640880

ABSTRACT

In this study, we produce highly porous (up to ∼91%) composite scaffolds of polylactic acid (PLA) containing 2 wt % sol-gel-derived 45S5 Bioglass® particles via nonsolvent induced phase separation at -23°C with no sacrificial phases involved. Before the incorporation of the bioglass with PLA, the particles are surface modified with a silane coupling agent which effectively diminishes agglomeration between them leading to a better dispersion of bioactive particles throughout the scaffold. Interestingly, the incorporation route (via solvent dichloromethane or nonsolvent hexane) of the surface modified particles in the foaming process has the greatest impact on porosity, crystallinity, and morphology of the scaffolds. The composite scaffolds with a morphology consisting of both mesopores and large macropores, which is potentially beneficial for bone regeneration applications, are examined further. SEM images show that the surface modified bioglass particles take-up a unique configuration within the mesoporous structure of these scaffolds ensuring that the particles are well interlocked but not completely covered by PLA such that they can be in contact with physiological fluids. The results of preliminary in vitro tests confirm that this PLA/bioglass configuration promotes the interaction of the bioactive phase with physiological fluids. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 105B: 2433-2442, 2017.


Subject(s)
Glass/chemistry , Polyesters/chemistry , Tissue Scaffolds/chemistry , Phase Transition , Porosity
7.
Health Educ Res ; 30(5): 693-705, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26338986

ABSTRACT

Little is known about how ophthalmologist-patient communication over time is associated with glaucoma patient long-term adherence. The purpose of our study was to examine the association between provider use of components of the resources and supports in self-management model when communicating with patients and adherence to glaucoma medications measured electronically over an 8-month period. In this longitudinal prospective cohort study, the main variables studied were ophthalmologist communication-individualized assessment, collaborative goal setting and skills enhancement. Patients with glaucoma who were newly prescribed or on glaucoma medications were recruited from six ophthalmology clinics. Patients' baseline and next follow-up visits were videotape-recorded. Patients were interviewed after their visits. Patients used medication event monitoring systems (MEMS) for 8 months after enrollment into the study, and adherence was measured electronically using MEMS for 240 days after their visits. Two hundred and seventy-nine patients participated. Patient race and regimen complexity were negatively associated with glaucoma medication adherence over an 8-month period. Provider communication behaviors, including providing education and positive reinforcement, can improve patient adherence to glaucoma medications over an 8-month period.


Subject(s)
Communication , Glaucoma/drug therapy , Medication Adherence , Physician-Patient Relations , Adult , Aged , Female , Humans , Male , Middle Aged , Surveys and Questionnaires , Videotape Recording
8.
Brain Cogn ; 99: 1-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26188845

ABSTRACT

BACKGROUND: Attention-Deficit/Hyperactivity Disorder (ADHD) is a heterogeneous, neurodevelopmental disorder which co-occurs often with Reading Disability (RD). ADHD with and without RD consistently have higher inattentive ratings compared with typically developing controls, with co-occurring ADHD and RD also demonstrating impaired phonological processing. Accordingly, inattention has been associated with greater phonological impairment, though the neural correlates of the association are poorly understood from a functional neuroimaging perspective. It was postulated that only the co-occurring subgroup would demonstrate hypoactivation of posterior, left hemispheric, reading-related areas and, to a lesser extent, alterations in right hemispheric, attention areas compared with controls. METHODS: A novel word rhyming Continuous Performance Task assesses functional activation differences in phonology- and attention-related areas between three groups: ten boys with ADHD and RD, fourteen boys with ADHD without RD, and fourteen typically developing controls. Subjects respond to words that rhyme with a target word as mono- and disyllabic, English words are visually presented over 90s blocks. RESULTS: Behavioral performance was not different between groups. Some hypoactivation of left hemispheric, reading-related areas was apparent in ADHD and RD, but not ADHD without RD, compared with controls. Right hemispheric, attention areas showed alterations in both ADHD subgroups relative to controls; however, the differences for each subgroup were dissimilar. CONCLUSIONS: The dorsal decoding subnetwork may not be grossly compromised in ADHD with Reading Disability. The role of cognitive impairments, including the level of inattention, on phonology requires clarification from a neuroimaging perspective.


Subject(s)
Attention Deficit Disorder with Hyperactivity/physiopathology , Attention/physiology , Dominance, Cerebral/physiology , Dyslexia/physiopathology , Phonetics , Semantics , Verbal Learning/physiology , Adolescent , Adult , Brain Mapping , Child , Female , Humans , Magnetic Resonance Imaging , Male , Neuropsychological Tests , Reference Values
9.
Mater Sci Eng C Mater Biol Appl ; 40: 248-52, 2014 Jul 01.
Article in English | MEDLINE | ID: mdl-24857490

ABSTRACT

More than four decades after the discovery of 45S5 Bioglass® as the first bioactive material, this composition is still one of the most promising materials in the tissue engineering field. Sol-gel-derived bioactive glasses generally possess improved properties over other bioactive glasses, because of their highly porous microstructure and unique surface chemistry which accelerate hydroxyapatite formation. In the current study, a new combination of precursors with lactic acid as the hydrolysis catalyst have been employed to design an organic, nitrate-free sol-gel procedure for synthesizing of 45S5 Bioglass®. This straightforward route is able to produce fully amorphous submicron particles of this glass with an appropriately high specific surface area on the order of ten times higher than that of the melt-derived glasses. These characteristics are expected to lead to rapid hydroxyapatite formation and consequently more efficient bone bonding.


Subject(s)
Ceramics/chemical synthesis , Gels/chemistry , Bone Cements/chemistry , Catalysis , Ceramics/chemistry , Durapatite/chemistry , Glass/chemistry , Hydrolysis , Lactic Acid/chemistry , Nitrates/chemistry , Surface Properties , Tissue Engineering
10.
Curr Med Res Opin ; 25(8): 1879-88, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19530975

ABSTRACT

BACKGROUND: The prevalence of open angle glaucoma increases with age, with many patients also receiving medications for non-ocular systemic diseases. Little is known about how systemic medications impact on the need for adjunctive therapy with prostaglandin analogues (PGA). OBJECTIVES: To evaluate whether systemic medications for hypertension, cholesterol, or glucose influence the need for adjunctive intraocular pressure (IOP) lowering medications in patients using PGAs. METHODS: Pharmaceutical records from the Québec prescription database provided a sample of patients receiving prescriptions for bimatoprost, latanoprost, or travoprost, from which subjects receiving > or =1 prescription for antihypertensives, antidiabetics. diuretics, and statins were identified. Chi-square tests compared proportions using PGAs to those using PGAs + adjunctive therapy, based on the use or non-use of systemic medications; a logistic regression was performed post hoc to adjust for gender and age. RESULTS: Of the 8548 evaluated patients (all using PGAs); 2934 (34.3%) took none of the studied systemic drugs. For the 5614 patients taking systemic medications, significantly fewer (p < 0.001) required an additional IOP lowering medication if taking a systemic antihypertensive medication. The use of a statin or a diabetic medication, alone or in combination, in addition to a PGA, made no significant difference in the need for adjunct glaucoma therapy. Individual drugs associated with significantly less utilization of adjunctive glaucoma medications were calcium-channel blockers, angiotensin-converting enzyme (ACE), and combination antihypertensive therapies. DISCUSSION: A profound association between systemic antihypertensive use and a reduced need for adjunct topical IOP lowering medications in patients using the same prostaglandin analogue for at least one year was found. LIMITATIONS: The use of a prescription claims database without patient compliance or patient outcomes may not reflect actual patient medication use. In addition, these findings may not be applicable to all patients initiating prostaglandin analogues. CONCLUSIONS: In this real-world population-based evaluation, a significant association exists between using systemic antihypertensive medications and reduced use of adjunctive IOP lowering therapies. These results confirm findings from previous studies suggesting an IOP lowering effect with systemic agents or some synergy with topical therapies.


Subject(s)
Antihypertensive Agents/pharmacology , Diuretics/pharmacology , Glaucoma/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hypoglycemic Agents/pharmacology , Prostaglandins, Synthetic/therapeutic use , Adult , Aged , Aged, 80 and over , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/therapeutic use , Databases as Topic , Diuretics/administration & dosage , Diuretics/therapeutic use , Female , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Male , Middle Aged , Quebec , Young Adult
12.
Ann Rheum Dis ; 66(2): 235-41, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16926184

ABSTRACT

BACKGROUND: Optimal use of disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis is vital if progression of disease is to be reduced. Methotrexate (MTX) and sulfasalazine (SASP) are widely used inexpensive DMARDs, recently often combined despite no firm evidence of benefit from previous studies. AIM: To establish whether a combination of SASP and MTX is superior to either drug alone in patients with rheumatoid arthritis with a suboptimal response to 6 months of SASP. METHODS: A randomised controlled study of step-up DMARD treatment in early rheumatoid arthritis. In phase I, 687 patients received SASP for 6 months. Those with a disease activity score (DAS) > or =2.4 were offered additional treatment in phase II (SASP alone, MTX alone or a combination of the two). The primary outcome measure was change in DAS. RESULTS: At 6 months, 191 (28%) patients had a DAS <2.4, 123 (18%) were eligible but did not wish to enter phase II, 130 (19%) stopped SASP because of reversible adverse events and 165 (24%) entered phase II. DAS at 18 months was significantly lower in those who received combination treatment compared with those who received either SASP or MTX: monotherapy arms did not differ. Improvement in European League Against Rheumatism and American College of Rheumatology 20, 50 and 70 scores favoured combination therapy. CONCLUSIONS: In this "true-to-life" study, an inexpensive combination of DMARDs proved more effective than monotherapy in patients with rheumatoid arthritis with a suboptimal response to SASP. There was no increase in toxicity. These results provide an evidence base for the use of this combination as a component of tight control strategies.


Subject(s)
Antirheumatic Agents/administration & dosage , Arthritis, Rheumatoid/drug therapy , Methotrexate/administration & dosage , Sulfasalazine/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , Antirheumatic Agents/adverse effects , Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/diagnostic imaging , Arthrography , Double-Blind Method , Drug Administration Schedule , Drug Therapy, Combination , Female , Humans , Male , Methotrexate/adverse effects , Methotrexate/therapeutic use , Middle Aged , Scotland , Sulfasalazine/adverse effects , Sulfasalazine/therapeutic use , Treatment Outcome
13.
Br J Ophthalmol ; 88(10): 1237-41, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15377541

ABSTRACT

AIM: To determine utilisation of eye care services in a rural population of southern India aged 40 years or older. METHODS: 5150 subjects aged 40 years and older selected through a random cluster sampling technique from three districts in southern India underwent detailed ocular examinations for vision impairment, blindness, and ocular morbidity. Information regarding previous use of eye care services was collected from this population through a questionnaire administered by trained social workers before ocular examinations. RESULTS: 3476 (72.7%) of 5150 subjects examined required eye care examinations. 1827 (35.5%) people gave a history of previous eye examinations, primarily from a general hospital (n = 1073, 58.7%). Increasing age and education were associated with increased utilisation of eye care services. Among the 3323 people who had never sought eye care, 912 (27.4%) had felt the need to have an eye examination but did not do so. Only one third of individuals with vision impairment, cataracts, refractive errors, and glaucoma had previously utilised services. CONCLUSIONS: A large proportion of people in a rural population of southern India who require eye care are currently not utilising existing eye care services. Improved strategies to improve uptake of services is required to reduce the huge burden of vision impairment in India.


Subject(s)
Eye Diseases/diagnosis , Patient Acceptance of Health Care/statistics & numerical data , Rural Health/statistics & numerical data , Adult , Age Distribution , Age Factors , Aged , Cross-Sectional Studies , Educational Status , Eye Diseases/epidemiology , Female , Humans , India/epidemiology , Male , Middle Aged , Vision Disorders/diagnosis , Vision Disorders/epidemiology
14.
Br J Ophthalmol ; 88(8): 989-94, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15258010

ABSTRACT

AIM: To determine risk factors for lens opacities and age related cataract in an older rural population of southern India. METHODS: A cross sectional population based study of 5150 people aged 40 years and above from 50 clusters from three districts in southern India. The lens was graded and classified after dilation using LOCS III system at the slit lamp for cataract. Definite cataract was defined as nuclear opalescence >/=3.0 and/or cortical cataract >/=3.0 and/or PSC >/=2.0. RESULTS: Definite cataracts were found in 2449 (47.5%) of 5150 subjects and the prevalence of cataract increased with age. The age adjusted prevalence of cataract was significantly lower in males (p = 0.0002). Demographic risk factors-increasing age and illiteracy-were common for the three subtypes of cataract; females were more likely to have cortical cataracts and nuclear cataracts. Additionally, nuclear cataracts were associated with moderate smoking (OR:1.28, 95% CI:1.01 to 1.64), lean body mass indices (OR: 1.37, 95% CI: 1.17 to 1.59) and higher waist to hip ratios (OR: 0.67, 95% CI: 0.54 to 0.82); cortical cataracts with hypertension (OR: 1.39 95% CI:1.11 to 1.72), pseudoexfoliation (OR:1.53,95% CI:1.17 to 2.01), and moderate to heavy smoking; and posterior subcapsular cataracts with diabetes (OR:1.55, 95% CI:1.12 to 2.15), lean body mass (OR:1.32, 95% CI:1.11 to 1.57), and high waist to hip ratios (OR: 0.77, 95% CI: 0.62 to 0.94). CONCLUSIONS: Risk factors for age related cataract in this population do not appear to be different from those reported in other populations. Further studies are required to identify the reason for the high prevalence of age related cataract and to understand better the role of each risk factor for cataractogenesis in this population.


Subject(s)
Cataract/epidemiology , Adult , Age Distribution , Aged , Body Constitution , Body Mass Index , Cataract/complications , Cataract Extraction , Diabetes Complications , Educational Status , Epidemiologic Methods , Female , Humans , Hypertension/complications , India/epidemiology , Male , Middle Aged , Rural Population , Sex Distribution , Smoking/adverse effects
15.
J Cataract Refract Surg ; 27(11): 1864-71, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11709262

ABSTRACT

A survey of glaucoma surgery parameters was mailed to all the United States members of the American Society of Cataract and Refractive Surgery in 1999 and 2000. Of the 5659 surveys mailed, 725 (13%) were returned. The survey assessed parameters used in glaucoma surgical treatment. Preferred surgery treatment patterns were cross-tabulated with fellowship training in glaucoma (9.3%) and geographic location. This report summarizes current practice styles and patterns of comprehensive ophthalmologists in the United States as derived from the survey.


Subject(s)
Filtering Surgery/statistics & numerical data , Glaucoma/surgery , Ophthalmology/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Cross-Sectional Studies , Filtering Surgery/trends , Fluorouracil/therapeutic use , Health Surveys , Humans , Middle Aged , Mitomycin/therapeutic use , Ophthalmology/trends , Practice Patterns, Physicians'/trends , Societies, Medical/statistics & numerical data , Surveys and Questionnaires , United States
16.
Am J Ophthalmol ; 129(3): 323-7, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10704547

ABSTRACT

PURPOSE: To evaluate an algorithm for the identification of glaucomatous visual field defects with the screening mode of frequency doubling technology. METHODS: Screening-mode frequency doubling technology and Swedish interactive threshold algorithm perimetry were performed on 137 of 150 consecutive patients referred to a glaucoma specialist. We created an algorithm for the frequency doubling technology that gave increased importance to both more severe defects and defects closer to fixation. These values were then compared with the results of the Swedish interactive threshold algorithm visual fields evaluated by the glaucoma hemifield test, two masked glaucoma specialists, and a published definition of glaucomatous damage to determine sensitivity and specificity of the frequency doubling technology screening mode for detecting glaucoma.


Subject(s)
Algorithms , Glaucoma/diagnosis , Optic Disk/pathology , Optic Nerve Diseases/diagnosis , Vision Disorders/diagnosis , Visual Field Tests/statistics & numerical data , Visual Fields , Adult , Aged , Aged, 80 and over , Data Interpretation, Statistical , Female , Humans , Intraocular Pressure , Male , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity , Visual Acuity
18.
J Am Acad Child Adolesc Psychiatry ; 38(12): 1482-9, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10596247

ABSTRACT

OBJECTIVE: To compare the effectiveness of behavioral family systems therapy (BFST) with that of ego-oriented individual therapy (EOIT) as treatments for adolescents with anorexia nervosa. METHOD: Thirty-seven adolescents meeting DSM-III-R criteria for anorexia nervosa were randomly assigned to receive BFST or EOIT, in addition to a common medical and dietary regimen. In BFST, the family was seen conjointly, the parents were placed in control of the adolescent's eating, distorted beliefs were targeted through cognitive restructuring, and strategic/behavioral interventions were used to change family interactions. In EOIT, the adolescent was seen individually, with an emphasis on building ego strength and uncovering the dynamics blocking eating; parents were seen collaterally. Measures administered before, after, and at 1-year follow-up tapped body mass index, menstruation, eating attitudes, ego functioning, depression, and family interactions. RESULTS: BFST produced greater weight gain and higher rates of resumption of menstruation than EOIT. Both treatments produced comparably large improvements in eating attitudes, depression, and eating-related family conflict, but very few changes occurred on ego functioning. CONCLUSIONS: BFST and EOIT proved to be effective treatments for adolescents with anorexia nervosa, but BFST produced a faster return to health.


Subject(s)
Anorexia Nervosa/therapy , Family Therapy/methods , Adolescent , Anorexia Nervosa/complications , Anorexia Nervosa/diagnosis , Anxiety Disorders/complications , Anxiety Disorders/diagnosis , Body Mass Index , Family Relations , Female , Follow-Up Studies , Humans , Male , Mood Disorders/complications , Mood Disorders/diagnosis , Parents/psychology , Psychiatric Status Rating Scales , Self Concept , Treatment Outcome
19.
Pediatr Clin North Am ; 46(5): 1027-38, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10570703

ABSTRACT

ADHD persists into adolescence for 78% of the children diagnosed with this condition. It interferes with school performance, self-esteem, family relationships, and driving and predisposes teenagers to high-risk behaviors. Some teens are diagnosed with ADHD for the first time during the second decade of life. The pediatrician must be sensitive to the developmental changes of adolescence and involve the teenager in treatment decision making in order to maximize compliance with treatment regimens. Long-acting medications are generally preferable with ADHD adolescents. Anticipatory guidance should involve education about ADHD and advice on parenting principles and coping with academic problems. Although the pediatrician may provide counseling for mild school and family problems, in most cases, referrals to mental health professionals or educational specialists are necessary.


Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Adolescent , Attention Deficit Disorder with Hyperactivity/therapy , Counseling , Female , Humans , Male , Prognosis
20.
J Glaucoma ; 8(3): 199-203, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10376261

ABSTRACT

PURPOSE: This study was conducted to evaluate the ocular hypotensive efficacy, safety, and side effects of latanoprost 0.005% administered as adjunctive therapy in patients with Sturge-Weber syndrome (SWS) and glaucoma. METHODS: Commercially available latanoprost 0.005% was added as a single drop once daily to other antiglaucoma medications. Intraocular pressure (IOP) was measured at 1, 3, and 6 months of treatment. A successful response was defined as a reduction of at least 20% in IOP at the final follow-up evaluation without additional medical or surgical therapy and no adverse events related to latanoprost. RESULTS: 18 eyes of 18 patients with SWS and glaucoma were enrolled from 9 clinical centers. Mean baseline IOP was 28.4 +/- 7.1 mmHg (range, 17-42 mmHg). Using Kaplan-Meier analysis, a successful response to latanoprost was observed in 3 of 18 (16.7%) patients at the 6-month interval. Seven (38.9%) patients required surgery; three (16.7%) patients required additional medical therapy, seven (38.9%) patients had no change in therapy. One (5.6%) patient discontinued latanoprost treatment because of intolerable conjunctival hyperemia. Two successfully treated patients had significantly greater episcleral vessel engorgement after initiation of latanoprost therapy. CONCLUSION: Patients with SWS and glaucoma respond poorly to adjunctive latanoprost therapy and often require additional medical or surgical intervention. Increased episcleral vascular engorgement might result in greater operative risks should filtration surgery become necessary in these patients.


Subject(s)
Glaucoma, Open-Angle/drug therapy , Intraocular Pressure/drug effects , Prostaglandins F, Synthetic/therapeutic use , Sturge-Weber Syndrome/complications , Adolescent , Adult , Chemotherapy, Adjuvant , Child , Child, Preschool , Female , Follow-Up Studies , Glaucoma, Open-Angle/complications , Humans , Latanoprost , Male , Ophthalmic Solutions/administration & dosage , Ophthalmic Solutions/adverse effects , Ophthalmic Solutions/therapeutic use , Prostaglandins F, Synthetic/administration & dosage , Prostaglandins F, Synthetic/adverse effects , Safety , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...